This website uses cookies to ensure you have the best user experience. By continuing to use this website, you consent to our use of cookies. For more information, read our privacy policy.
This is a test.
Ovarian Cancer Canada and the Quebec-Clinical Research Organization in Cancer team up to improve access to vital resources
This is a test.
Advocacy in action: Making game-changing PARP Inhibitors accessible for women in Prince Edward Island
This is a test.
Canadian innovation in ovarian cancer research can save the lives of women in Canada and around the world
This is a test.
Clinical Trial: Targeting the targets – investigating an innovative chemotherapy alternative
This is a test.
Clinical Trial: New biomarkers, improved treatment pathways
This is a test.
Research knows no bounds
This is a test.
Prize awarded to researcher whose ovarian cancer vaccines are in preclinical studies funded by Ovarian Cancer Canada
This is a test.
Ovarian Cancer Canada and the Cancer Research Society invest $2.25 million
This is a test.
Harnessing the power of vaccines to treat ovarian cancer
